McDonald Jennifer S, Carter Rickey E, Karnes R Jeffrey, Port John D, Kawashima Akira, Carlson Stephanie K, Bender Claire E
1 Department of Radiology, Mayo Clinic, 200 1st St SW, Rochester, MN 55905.
2 Department of Health Sciences Research, Mayo Clinic, Rochester, MN.
AJR Am J Roentgenol. 2015 Nov;205(5):1008-15. doi: 10.2214/AJR.14.13766.
The American College of Radiology (ACR) Appropriateness Criteria panel has recommended that patients with prostate cancer who have received treatment undergo imaging only after suspected cancer recurrence. We examined whether local physicians followed this recommendation and what types of imaging examinations were ordered in a cohort of patients with local prostate cancer.
The Rochester Epidemiology Project, a research consortium that collects, links, and stores medical record information of Olmsted County, Minnesota, residents, was used to capture the complete medical history of treated patients with prostate cancer from 2000 through 2011. Clinical information and imaging examinations performed were retrieved by chart review. Suspected recurrence was defined as treatment-specific prostate-specific antigen level elevations, bone pain, or abnormal digital rectal examination findings.
Of the 670 treated patients with prostate cancer who were included in the final analysis, 129 (19%) underwent posttreatment imaging. After excluding imaging related to retreatment or another cancer, 13 patients (i.e., 2% of the entire cohort and 10% of imaged patients) underwent imaging in the absence of suspected recurrence. A total of 90 patients (70% of imaged patients) underwent imaging after suspected recurrence. Of these 90 patients, 62 (69%) underwent a bone scan as their first imaging modality either alone or in combination with other imaging modalities. Of the providers who ordered a bone scan first, 27% were urologists, 23% were radiation oncologists, and 24% were primary care physicians.
Most patients in this study did not undergo imaging in the absence of suspected recurrence. Various types of imaging examinations were ordered for patients with suspected recurrence.
美国放射学会(ACR)适宜性标准小组建议,接受过治疗的前列腺癌患者仅在怀疑癌症复发后才进行影像学检查。我们研究了当地医生是否遵循这一建议,以及在一组局部前列腺癌患者中所开具的影像学检查类型。
罗切斯特流行病学项目是一个研究联盟,收集、关联并存储明尼苏达州奥尔姆斯特德县居民的病历信息,用于获取2000年至2011年接受治疗的前列腺癌患者的完整病史。通过查阅病历检索临床信息和所进行的影像学检查。怀疑复发定义为特定治疗后的前列腺特异性抗原水平升高、骨痛或直肠指检异常结果。
在最终分析纳入的670例接受过治疗的前列腺癌患者中,129例(19%)接受了治疗后影像学检查。在排除与再次治疗或其他癌症相关的影像学检查后,13例患者(即占整个队列的2%和接受影像学检查患者的10%)在没有怀疑复发的情况下接受了影像学检查。共有90例患者(占接受影像学检查患者的70%)在怀疑复发后接受了影像学检查。在这90例患者中,62例(69%)首先单独或与其他影像学检查联合进行了骨扫描作为其首次影像学检查方式。在首先开具骨扫描的医疗服务提供者中,27%是泌尿科医生,23%是放射肿瘤学家,24%是初级保健医生。
本研究中的大多数患者在没有怀疑复发的情况下未接受影像学检查。对于怀疑复发的患者开具了各种类型的影像学检查。